Healthcare provider profile · identity verified

Daniel Patrick Sapp, D.O.

Emergency Medicine · SALEM, VA · NPI 1447646294

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Eliquis	Apixaban	364	50
Atorvastatin Calcium	Atorvastatin Calcium	342	86
Sertraline Hcl	Sertraline Hcl	229	43
Levothyroxine Sodium	Levothyroxine Sodium	226	49
Trazodone Hcl	Trazodone Hcl	209	52
Furosemide	Furosemide	196	57
Amlodipine Besylate	Amlodipine Besylate	170	40
Metoprolol Tartrate	Metoprolol Tartrate	168	41
Tamsulosin Hcl	Tamsulosin Hcl	165	40
Levetiracetam	Levetiracetam	127	17
Januvia	Sitagliptin Phosphate	121	suppressed
Divalproex Sodium	Divalproex Sodium	113	25
Metformin Hcl	Metformin Hcl	112	25
Potassium Chloride	Potassium Chloride	105	25
Clopidogrel	Clopidogrel Bisulfate	102	19
Enulose	Lactulose	93	16
Pantoprazole Sodium	Pantoprazole Sodium	93	34
Mirtazapine	Mirtazapine	92	23
Fluoxetine Hcl	Fluoxetine Hcl	89	14
Carvedilol	Carvedilol	85	22
Lisinopril	Lisinopril	85	25
Buspirone Hcl	Buspirone Hcl	82	21
Hydralazine Hcl	Hydralazine Hcl	80	19
Latanoprost	Latanoprost	78	17
Spironolactone	Spironolactone	70	suppressed
Jardiance	Empagliflozin	69	14
Baclofen	Baclofen	68	11
Finasteride	Finasteride	67	11
Oxcarbazepine	Oxcarbazepine	67	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	65	16
Lamotrigine	Lamotrigine	65	11
Allopurinol	Allopurinol	64	14
Montelukast Sodium	Montelukast Sodium	62	11
Ceftriaxone	Ceftriaxone Sodium	61	32
Doxycycline Monohydrate	Doxycycline Monohydrate	61	suppressed
Ondansetron Hcl	Ondansetron Hcl	61	21
Losartan Potassium	Losartan Potassium	60	22
Duloxetine Hcl	Duloxetine Hcl	58	21
Risperidone	Risperidone	58	suppressed
Simvastatin	Simvastatin	56	12
Quetiapine Fumarate	Quetiapine Fumarate	55	17
Divalproex Sodium Er	Divalproex Sodium	54	12
Bupropion Xl	Bupropion Hcl	53	suppressed
Paroxetine Hcl	Paroxetine Hcl	52	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	51	26
Midodrine Hcl	Midodrine Hcl	50	13
Omeprazole	Omeprazole	48	17
Cefdinir	Cefdinir	47	36
Metoprolol Succinate	Metoprolol Succinate	46	17
Venlafaxine Hcl Er	Venlafaxine Hcl	45	suppressed
Donepezil Hcl	Donepezil Hcl	43	12
Olanzapine	Olanzapine	43	suppressed
Scopolamine	Scopolamine	43	suppressed
Trulicity	Dulaglutide	43	suppressed
Methocarbamol	Methocarbamol	42	17
Prednisone	Prednisone	40	35
Gemtesa	Vibegron	39	suppressed
Memantine Hcl	Memantine Hcl	39	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	39	36
Ramelteon	Ramelteon	39	15
Cephalexin	Cephalexin	38	19
Alendronate Sodium	Alendronate Sodium	36	suppressed
Sodium Chloride	0.9 % Sodium Chloride	36	22
Brimonidine Tartrate	Brimonidine Tartrate	35	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	35	14
Myrbetriq	Mirabegron	35	suppressed
Fluticasone Propionate	Fluticasone Propionate	33	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	33	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	32	23
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	11
Amiodarone Hcl	Amiodarone Hcl	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Gabapentin	Gabapentin	31	20
Bumetanide	Bumetanide	30	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	29	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	29	12
Ursodiol	Ursodiol	28	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	27	suppressed
Lidocaine Hcl	Lidocaine Hcl/Pf	27	20
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Sucralfate	Sucralfate	27	suppressed
Azithromycin	Azithromycin	26	21
Levofloxacin	Levofloxacin	26	19
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Pravastatin Sodium	Pravastatin Sodium	26	suppressed
Propranolol Hcl Er	Propranolol Hcl	26	suppressed
Risperdal Consta	Risperidone Microspheres	26	suppressed
Fenofibrate	Fenofibrate,micronized	25	suppressed
Incruse Ellipta	Umeclidinium Bromide	25	suppressed
Primidone	Primidone	25	suppressed
Clozapine	Clozapine	24	suppressed
Famotidine	Famotidine	24	16
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	14
Entresto	Sacubitril/Valsartan	23	suppressed
Tizanidine Hcl	Tizanidine Hcl	23	suppressed
Bicalutamide	Bicalutamide	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Torsemide	Torsemide	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Glipizide	Glipizide	20	suppressed
Nystatin	Nystatin	20	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Phenytoin	Phenytoin	19	suppressed
Prazosin Hcl	Prazosin Hcl	19	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	19	suppressed
Silodosin	Silodosin	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	14
Atenolol	Atenolol	18	suppressed
Benztropine Mesylate	Benztropine Mesylate	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Ertapenem	Ertapenem Sodium	18	11
Lyumjev Kwikpen U-100	Insulin Lispro-Aabc	18	suppressed
Ondansetron Odt	Ondansetron	18	18
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Cefuroxime	Cefuroxime Axetil	17	11
Levemir Flexpen	Insulin Detemir	17	suppressed
Oxycodone Hcl	Oxycodone Hcl	17	13
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Carbamazepine	Carbamazepine	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Lidocaine Hcl	Lidocaine Hcl	16	12
Methenamine Hippurate	Methenamine Hippurate	16	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Albuterol Sulfate	Albuterol Sulfate	15	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	15	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Timolol Maleate	Timolol Maleate	15	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Cefepime Hcl	Cefepime Hcl	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Glycopyrrolate	Glycopyrrolate	13	suppressed
Moxifloxacin	Moxifloxacin Hcl	13	suppressed
Clindamycin Hcl	Clindamycin Hcl	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Dulera	Mometasone/Formoterol	11	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Nyamyc	Nystatin	11	11
Promethazine Hcl	Promethazine Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Tradjenta	Linagliptin	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error